Piperacillin/Tazobactam for Injection Recalled due to Foreign Particulate

Health Canada warns particulate may even be visible

PPC (Pharmaceutical Partners of Canada Inc.), in consultation with Health Canada is recalling Lot 7101490 of Piperacillin/Tazobactam for Injection, 4.5 g/vial (DIN 02305615) due to the finding of the presence of foreign particulate matter in some vials from this lot.

Using vials from this lot could lead to the administration of foreign, particulate matter into the blood stream that may lead to potential adverse events such as phlebitis (inflammation of a vein), or thrombosis.

The physiological effect of the foreign particulate matter will depend on the size of the particle, particle composition, number of particles, the rate at which the particles are introduced, and the state of the patient receiving the product. Patients who have had previous trauma, undergone major surgery, or suffer from other conditions that adversely affect the microvascular blood supply of tissues and vital organs may be at greater risk.

Legal Help

If you or a loved one has suffered adverse health effects from this product, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Published on Jan-5-09